Ledger.Open graph →
SEC Form D · Amendment · filed September 19, 2022

CytoDyn Inc

Offering
$21.8M
Sold
$21.8M
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
Vancouver, WA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (22)

Tanya D. Urbach · Vancouver, WADirectorKaren J. Brunke · Vancouver, WADirectorLishomwa C. Ndhlovu · Vancouver, WADirectorNitya G. Ray · Vancouver, WAExecAntonio D. Migliarese · Vancouver, WAExecScott A. Kelly · Vancouver, WAExec · DirectorKen M. Manning · Iowa City, IAExecJoseph M. Varnas · San Francisco, CAExec · DirectorDaniel M. Krzmarzick · Iowa City, IADirectorRobert L. Clark · Boston, MADirectorErika M. Crandall · San Francisco, CADirectorBrian M. Gragnolati · Iowa City, IAExecRyan G. Dunlap · Vancouver, WADirectorArvin C. Arman · Vancouver, WAExecNeil S. Mehta · Orinda, CAExecAmanda Drobnis · Mansfield, MAExecJessica Mclear · Mansfield, MADirectorAlan Watson · Mansfield, MAExec · DirectorSusan Mason · Franklin, TNDirectorChristine Campanelli · CHICAGO, ILDirectorRyan G. Dunlap · Vancouver, WADirectorArvin C. Arman · Vancouver, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗